Finantzaketa
Finantzatzailea: FUNDACIÓN BANCARIA LA CAIXA
15 finantziazioak
2025
2024
-
Uncovering resistance mechanism to CAR-T cells via deep learning in scRNAseq for improved therapies
359.500,00 €
-
Uncovering resistance mechanism to CAR-T cells via deep learning in scRNAseq for improved therapies
309.650,00 €
-
LncRNAs modulating DNA damage and repair: towards novel therapies for hepatocellular carcinoma
394.903,00 €
-
Generation of humanized organs from human iPS cells.
500.026,00 €
2021
-
ACTILNET. INTERLEUKIN-8 AND NEUTROPHIL EXTRACELULAR TRAPS AS ACTIONABLE HURDLES FOR CANCER IMMUNOTHERAPY
498.850,00 €
-
lncRNAs-RS-CRC. Understanding lncRNAs in replicative stress and colorectal cancer: from cancer biology to single-molecules
375.000,00 €
-
Niños Contra el Cáncer (3 Convenio FDBLC)
100.000,00 €
2020
-
HR20-00871 GR-NET NORMAL-HIT David Lara
153.850,00 €
-
Gene Regulatory NETworks in NORmal and MALignant Hematopoiesis- Identification and Targeting (GR-NET NORMAL-HIT
411.250,00 €
-
Riboswitches On U1 snRNP for Therapeutic Expression Regulation
70.000,00 €
-
PLA2G4E: a new target for dementia treatment
70.000,00 €